Rejuvenate Bio secures $4M to advance gene therapy for a devastating heart disease
BioProcess International - 27-Aug-2024A promising one-time treatment approach for arrhythmogenic cardiomyopathy
Join the club for FREE to access the whole archive and other member benefits.
Editor and BioProcess Insider
Josh Abbott is the Editor and BioProcess Insider at Informa Connect. Previously, he worked as reporter for Herald and News and as administrative assistant for Mountain Rose Herbs.
Abbott holds a bachelor's degree in Journalism from the University of Oregon.
Visit website: https://www.bioprocessintl.com/author/josh-abbott
See alsoDetails last updated 15-Sep-2024
A promising one-time treatment approach for arrhythmogenic cardiomyopathy